enVista Envy Toric IOLRecalls & reported problems across all models
Bausch & Lomb Incorporated · 513 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names at least one enVista Envy Toric IOL model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 39
- Deaths reported
- 0
- Injuries reported
- 39
- Recalls
- 1
We found 513 models of enVista Envy Toric IOL by Bausch & Lomb Incorporated in the FDA's device registry (GUDID). Together they are named in 39 adverse event reports in the FDA's MAUDE database, received between Feb 19, 2025 and Sep 24, 2026 — classified as 39 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (16 reports).
1 FDA recall record name at least one of these models by its device identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
enVista Envy Toric IOL recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Mar 27, 2025Open, Classified
In response to an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with implantation of enVista Aspire and enVista Envy IOLs, and certain enVista monofocal lenses in the U.S.
Z-1680-2025 · Root cause: Process control · names 513 of these models · Recall details · FDA record ↗
Most reported enVista Envy Toric IOL problems
Device problems
- Insufficient Device Problem Information16
- Adverse Event Without Identified Device or Use Problem13
- Device Dislodged or Dislocated4
- Break2
- Manufacturing, Packaging or Shipping Problem2
- Unintended Movement2
- Patient Device Interaction Problem1
Patient problems
- Toxic Anterior Segment Syndrome (TASS)12
- Visual Impairment11
- Visual Disturbances8
- Halo5
- Hypopyon5
- Inflammation5
- Intraocular Pressure Increased5
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available4
enVista Envy Toric IOL models
513 models, 100 per page, most reported first. Each model has its own page with its reports, recalls and device details.
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall5 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall2 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall2 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall2 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall2 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall1 report
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
- enVista Envy™ Toric IOL ETNLens, Multifocal Intraocular1 recall0 reports
Recent enVista Envy Toric IOL adverse event reports
The 15 most recent reports across all models, in the reporter's own words as published by the FDA.
InjurySep 24, 2026Adverse Event Without Identified Device or Use Problem
It was reported that after implantation of an intraocular lens (IOL) into the right eye, the patient was dissatisfied with the postoperative visual outcome. Initially, the patient declined an IOL exchange due to satisfaction with near vision. Subsequently, the IOL was exchanged with a different model lens. Additional information was requested but not received.
Patient problems: Unspecified Eye / Vision Problem
MAUDE report 50889711 ↗InjurySep 22, 2026Adverse Event Without Identified Device or Use Problem
It was reported following right eye intraocular lens (IOL) implantation, the patient experienced blurry vision and glares. The implanted IOL was explanted and replaced with a different model lens of a different power. The patient subsequently recovered.
Patient problems: Blurred Vision
MAUDE report 50855220 ↗InjurySep 22, 2026Adverse Event Without Identified Device or Use Problem
It was reported following left eye intraocular lens (IOL) implantation, the patient experienced blurry vision and glares. Approximately three months later, the implanted IOL was explanted and replaced with a different model lens of a different power. The patient subsequently recovered.
Patient problems: Blurred Vision
MAUDE report 50855106 ↗InjuryMay 29, 2026Device Dislodged or Dislocated
IT WAS REPORTED THAT AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) IN THE RIGHT EYE (OD), THE LENS SUBSEQUENTLY DISLOCATED. APPROXIMATELY SIX WEEKS AFTER ONSET OF THE ISSUE, THE IOL WAS EXCHANGED FOR A DIFFERENT MODEL. IN THE SURGEON'S OPINION, THE MOST LIKELY CAUSE OF THE DISLOCATION WAS CAPSULE DAMAGE. IT IS NOT CLEAR WHEN THE CAPSULE DAMAGE HAPPENED. THE PATIENT¿S OUTCOME IS GOOD. ADDITIONAL INFORMATION INCLUDING CLARIFICATION REGARDING THE TIMING OF THE CAPSULE DAMAGE WAS REQUESTED BUT WAS NOT RECEIVED.
Patient problems: Capsular Bag Tear; Visual Impairment
MAUDE report 25330372 ↗InjuryMay 28, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT 1 DAY AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) IN THE RIGHT EYE (OD), THE PATIENT COMPLAINED OF GLARE. APPROXIMATELY 5 MONTHS AFTER SYMPTOM ONSET, THE INITIAL IOL WAS REMOVED AND REPLACED WITH A DIFFERENT MODEL LENS. IN THE SURGEON'S OPINION, THE MOST LIKELY CAUSE OF THE EVENT WAS THE LENS. THE PATIENT HAS RECOVERED.
Patient problems: Visual Disturbances
MAUDE report 25315771 ↗InjuryMay 19, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) IN THE LEFT EYE (OS), THE PATIENT COMPLAINED OF SEEING TOO MANY HALOS. APPROXIMATELY 2 MONTHS AFTER IMPLANTATION, THE IOL WAS EXCHANGED FOR A DIFFERENT MODEL. IN THE SURGEON'S OPINION, THE MOST LIKELY CAUSE OF THE EVENT IS UNKNOWN. THE PATIENT'S OUTCOME IS GOOD.
Patient problems: Halo
MAUDE report 25215656 ↗InjuryMay 14, 2026Adverse Event Without Identified Device or Use Problem
A USER FACILITY REPORTED THAT FOLLOWING IMPLANTATION OF AN INTRAOCULAR LENS (IOL), THE PATIENT EXPERIENCED GLARE. THE LENS WAS SUBSEQUENTLY EXPLANTED AND REPLACED WITH AN ALTERNATIVE INTRAOCULAR LENS. THE MODEL AND MANUFACTURER OF THE REPLACEMENT LENS WERE NOT PROVIDED. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Visual Disturbances
MAUDE report 25173522 ↗InjuryApr 29, 2026Adverse Event Without Identified Device or Use Problem
A SURGEON REPORTED THAT A WEEK AFTER THE IMPLANTATION OF A TORIC MULTIFOCAL INTRAOCULAR LENS (IOL) INTO THE PATIENTS RIGHT EYE (OD) THE PATIENT WAS NOT SATISFIED WITH THEIR VISION AND HAD ISSUES WITH GLARE AND HALOS AT NIGHT. SIX MONTHS AFTER INITIAL PLACEMENT THE IOL WAS EXPLANTED AND REPLACED WITH A TORIC MONOFOCAL IOL. THE PATIENT OUTCOME IS GOOD.
Patient problems: Halo; Visual Disturbances
MAUDE report 25028721 ↗InjuryApr 21, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT EXPERIENCED DYSPHOTOPSIA IN THE RIGHT EYE (OD) FOLLOWING AN INTRAOCULAR LENS (IOL) EXCHANGE. THE PATIENT HAD A FAVORABLE OUTCOME WITH THE MONOFOCAL IOL IN THE FELLOW EYE AND REQUESTED THAT THE RIGHT EYE IOL BE EXCHANGED FOR A MONOFOCAL AS WELL. A SECOND LENS EXCHANGE WAS SUBSEQUENTLY PERFORMED APPROXIMATELY TWO MONTHS AFTER THE FIRST EXCHANGE. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Visual Disturbances
MAUDE report 24938271 ↗InjuryMar 25, 2026Break
DURING INSERTION OF THE INTRAOCULAR LENS (IOL), THE TRAILING HAPTIC CAUGHT IN THE CARTRIDGE AS IT WAS BEING ADVANCED. THE HAPTIC WAS FREED AND THE LENS WAS SUBSEQUENTLY IMPLANTED IN THE PATIENT¿S EYE. THE HAPTIC WAS FOUND TO BE CRACKED AND DISLOCATED FROM THE CAPSULAR BAG, MIGRATING INTO THE SULCUS. TWO WEEKS POST IMPLANT THE HAPTIC WAS REPOSITIONED BACK INTO THE CAPSULAR BAG. THE LENS REMAINS IMPLANTED.
Patient problems: Insufficient Information
MAUDE report 24685638 ↗InjuryMar 5, 2026Break
A SURGERY CENTER REPORTED THAT DURING THE IMPLANTATION OF AN INTRAOCULAR LENS (IOL) THE HAPTIC CAME OFF THE LENS. THE LENS WAS CUT OUT AND REMOVED FROM THE PATIENT, LEAVING THEM APHAKIC. AN IOL OF THE SAME MODEL AND DIOPTER WAS IMPLANTED THREE DAYS LATER AT A DIFFERENT FACILITY. THE PATIENT HAS FULLY RECOVERED WITHOUT COMPLICATIONS.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 24517637 ↗InjuryJan 16, 2026Device Dislodged or Dislocated
THIS EVENT WAS ORIGINALLY REPORTED AS EVENT #2 FOR PATIENT IDENTIFIER (A)(1) (B)(6). SINCE PATIENT IDENTIFIERS WERE LATER PROVIDED, THE CASE HAS BEEN REASSIGNED TO PATIENT IDENTIFIER (A)(1) (B)(6). ADDITIONAL INFORMATION WAS RECEIVED INDICATING SIX MONTHS AFTER IMPLANTATION OF THE IOL IN THE PATIENT'S LEFT EYE (OS), THE PATIENT REPORTED THAT VISION WAS NO LONGER AS CRISP AS THREE MONTHS PRIOR. EXAMINATION AT THAT TIME IDENTIFIED INFERIOR DECENTRATION OF THE IOL AND PHIMOSIS OF THE ANTERIOR CAPSULE. NINE MONTHS POST-IMPLANTATION, DURING THE LENS EXCHANGE, A CAPSULAR TENSION RING WAS IMPLANTED DUE TO ZONULAR DEHISCENCE. ACCORDING TO THE SURGEON, THE MOST LIKELY CAUSE OF THE EVENT WAS A CHRONIC INFLAMMATORY STIMULUS FROM THE LENS. FOLLOWING THE EXCHANGE, THE SURGEON DISCUSSED WITH THE PATIENT THE OPTIONS OF PRK OR LASIK TO ENHANCE DISTANCE VISION. THE PATIENT CONTINUES TO REPORT SEEING HALOS, WHICH THE SURGEON ATTRIBUTES TO THE PATIENT'S INABILITY TO ADAPT TO THE LENS DESIGN.
Patient problems: Blurred Vision; Capsular Contracture; Halo; Inflammation; Zonular Dehiscence
MAUDE report 24095015 ↗InjuryJan 16, 2026Device Dislodged or Dislocated
ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THE SUPERIOR-TEMPORAL DECENTRATION AND MILD PHIMOSIS WAS OBSERVED APPROXIMATELY TWO WEEKS AFTER IMPLANTATION OF THE IOL IN THE PATIENT'S LEFT EYE (OS). THE IOL EXCHANGE WAS PERFORMED APPROXIMATELY TWO WEEKS AFTER THE ONSET OF PROBLEM. APPROXIMATELY ONE-WEEK POST-EXCHANGE, A YAG LASER CAPSULOTOMY WAS PERFORMED. AFTER THIS INTERVENTION, THE IOL WAS NOTED TO BE WELL CENTERED, ALTHOUGH THERE IS STILL MILD PHIMOSIS. ACCORDING TO THE SURGEON, THE MOST LIKELY CAUSE OF THE EVENT WAS A CHRONIC INFLAMMATORY STIMULUS FROM THE LENS.
Patient problems: Capsular Contracture; Inflammation
MAUDE report 24094966 ↗InjuryJan 16, 2026Adverse Event Without Identified Device or Use Problem
A SURGEON REPORTED THAT FOUR MONTHS POST RIGHT EYE IOL (INTRAOCULAR LENS) IMPLANTATION, THE LENS WAS EXPLANTED DUE TO THE PATIENT EXPERIENCING DYSPHOTOSIA. A NEW LENS OF THE SAME MODEL WAS PLACED AND THE PATIENT IS CURRENTLY DOING WELL.
Patient problems: Visual Disturbances
MAUDE report 24092584 ↗InjuryJan 15, 2026Device Dislodged or Dislocated
IT WAS REPORTED THAT APPROXIMATELY ONE MONTH AFTER IMPLANTATION OF AN INTRAOCULAR (IOL) LENS IN THE LEFT EYE (OS), THE SURGEON NOTED SUPERIOR DECENTRATION OF THE IOL AND CAPSULAR PHIMOSIS DURING SLIT LAMP EXAMINATION. THE PATIENT'S BEST CORRECTED VISUAL ACUITY (BCVA) DECREASED FROM 20/20 TO 20/25. APPROXIMATELY SIX WEEKS AFTER ONSET OF THE ISSUE, THE IOL WAS EXCHANGED FOR THE SAME MODEL WITH A DIFFERENT DIOPTER. ONE WEEK FOLLOWING THE EXCHANGE PROCEDURE, A YAG LASER CAPSULOTOMY WAS PERFORMED. THE PATIENT SUBSEQUENTLY RECOVERED. ACCORDING TO THE SURGEON, THE MOST LIKELY CAUSE OF THE EVENT WAS A CHRONIC INFLAMMATORY STIMULUS FROM THE LENS, NOTING FINDINGS OF 1+ CELLS ON POSTOPERATIVE DAY 1 AND AT THE TIME OF YAG TREATMENT. THE FOLLOWING MEDICATIONS WERE PRESCRIBED FOR USE AT HOME POST-OPERATIVELY: PROLENSA QD X 4 WEEKS. PRED 1% QID X 4 WEEKS-TAPER.
Patient problems: Capsular Contracture; Inflammation; Visual Impairment
MAUDE report 24085077 ↗
Other Bausch & Lomb Incorporated products
- enVista IOL74 models · 70 reports · 1 recall
- enVista Toric IOL450 models · 15 reports · 2 recalls
- enVista Envy IOL53 models · 52 reports · 1 recall
- Akreos IOL8 models · 10 reports · 1 recall
- enVista Aspire IOL57 models · 10 reports · 1 recall
- enVista Aspire Toric IOL513 models · 8 reports · 1 recall
- IC-8 Apthera IOL20 models · 38 reports
- SofPort IOL20 models · 29 reports
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page